Can OncoGenex Pharma (OGXI) Continue to Rise?

OncoGenex Pharmaceuticals Inc (OGXI) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because OGXI is now in overbought territory with an RSI value of 72.6. Furthermore, OncoGenex Pharma currently has a Zacks Rank #4 (Sell), suggesting that investors may want to consider exiting this stock now before it falls back to Earth.




ONCOGENEX PHARMACEUTICALS INC (OGXI): Free Stock Analysis Report


Zacks Investment Research

Advertisement